1. Home
  2. Products & Services
  3. Brands
  4. LIBATEC®

LIBATEC®

LIBATEC® is Wacker Biotech’s technology platform for developing and manufacturing Live Biotherapeutic Products (LBPs). We developed LIBATEC® to meet our customers’ growing need for LBPs, both for clinical and market supply. Customers of the LIBATEC® platform benefit from our wealth of experience in developing and optimizing LBP processes and in GMP production.

LIBATEC® – The Technology for Live Biotherapeutic Products
PDF 223 KBEnglish

Wacker Biotech has already manufactured a wide range of LBPs, including wild-type and genetically modified strains for use as live biotherapeutics, vaccines, immunotherapy and delivery systems for clinical and commercial use.

The LIBATEC® platform is ideal for manufacturing without hold times, and for maintaining the cell viability throughout the production process.

Advantages:

  • Over a decade of experience in LBP development and manufacturing
  • Fermentation regimes for aerobic and specific anaerobic organisms
  • Optimization of upstream and downstream processes
  • GMP-compliant drug substance manufacturing on various fermentation scales up to 1,500 liters, with integrated drug product production, including lyophilization
  • Closed production systems (monoseptic processing) in order to maintain culture purity, crucial to meeting customers’ and regulators’ quality requirements

Biopharma

Wacker Biotech is the microbial CDMO – your all-in-one partner of choice for contract manufacturing of biologics using microbial hosts.

GMP Manufacturing

LIBATEC® is manufactured in accordance with Good Manufacturing Practice (GMP) guidelines.

Microbial Technologies

LIBATEC® is one of our innovative technologies for the efficient and cost-effective production of biologics.

Wacker Biotech GmbH

Hans-Knöll-Strasse 3
07745 Jena
Germany

Contact us How to find us